These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 22001151)
1. Topical ciclosporin in the treatment of vernal keratoconjunctivitis in Rwanda, Central Africa: a prospective, randomised, double-masked, controlled clinical trial. De Smedt S; Nkurikiye J; Fonteyne Y; Tuft S; De Bacquer D; Gilbert C; Kestelyn P Br J Ophthalmol; 2012 Mar; 96(3):323-8. PubMed ID: 22001151 [TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis. Hingorani M; Moodaley L; Calder VL; Buckley RJ; Lightman S Ophthalmology; 1998 Sep; 105(9):1715-20. PubMed ID: 9754182 [TBL] [Abstract][Full Text] [Related]
3. A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study. Leonardi A; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Bremond-Gignac D; Ophthalmology; 2019 May; 126(5):671-681. PubMed ID: 30593775 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651 [TBL] [Abstract][Full Text] [Related]
5. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846 [TBL] [Abstract][Full Text] [Related]
6. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis. Kiliç A; Gürler B Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949 [TBL] [Abstract][Full Text] [Related]
7. Topical cyclosporin A in the management of vernal keratoconjunctivitis. Gupta V; Sahu PK Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292 [TBL] [Abstract][Full Text] [Related]
9. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis. Sharma A; Gupta R; Ram J; Gupta A Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021 [TBL] [Abstract][Full Text] [Related]
10. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related]
11. Topical cyclosporine a 0.05% eyedrops in the treatment of vernal keratoconjunctivitis - randomized placebo-controlled trial. Keklikci U; Dursun B; Cingu AK Adv Clin Exp Med; 2014; 23(3):455-61. PubMed ID: 24979519 [TBL] [Abstract][Full Text] [Related]
12. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis. Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977 [TBL] [Abstract][Full Text] [Related]
13. Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care. De Smedt SK; Nkurikiye J; Fonteyne YS; Tuft SJ; Gilbert CE; Kestelyn P Ophthalmology; 2012 Sep; 119(9):1766-72. PubMed ID: 22683059 [TBL] [Abstract][Full Text] [Related]
14. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Daniell M; Constantinou M; Vu HT; Taylor HR Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328 [TBL] [Abstract][Full Text] [Related]
15. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]
16. Tailored approach to the treatment of vernal keratoconjunctivitis. Sacchetti M; Lambiase A; Mantelli F; Deligianni V; Leonardi A; Bonini S Ophthalmology; 2010 Jul; 117(7):1294-9. PubMed ID: 20382430 [TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment of Vernal keratoconjunctivitis in pediatric age: pilot study on 197 patients]. Spadavecchia L; Fanelli P; Tesse R; Rizzo G; Procoli U; Bellizzi M; Armenio L Minerva Pediatr; 2010 Jun; 62(3):239-44. PubMed ID: 20467374 [TBL] [Abstract][Full Text] [Related]
18. Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis. Bremond-Gignac D; Doan S; Amrane M; Ismail D; Montero J; Németh J; Aragona P; Leonardi A; Am J Ophthalmol; 2020 Apr; 212():116-126. PubMed ID: 31770513 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of 1.25% and 1% topical cyclosporine in the treatment of severe vernal keratoconjunctivitis in childhood. Spadavecchia L; Fanelli P; Tesse R; Brunetti L; Cardinale F; Bellizzi M; Rizzo G; Procoli U; Bellizzi G; Armenio L Pediatr Allergy Immunol; 2006 Nov; 17(7):527-32. PubMed ID: 17014629 [TBL] [Abstract][Full Text] [Related]
20. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]